Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

HIV

New target for HIV vaccine found

The fusion peptide is a new region of interest for HIV vaccine development, researchers say.

Some people infected with HIV naturally produce broadly neutralising antibodies (bnAbs) against the virus. One strategy for vaccine development is to elicit the production of specific bnAbs from uninfected individuals, which would protect against HIV infection. 

US researchers, reporting in Science (online, 13 May 2016)[1], studied an HIV-infected person who produced potent bnAbs, but they hadn’t yet been able to identify the region of the virus recognised by the antibodies. 

By isolating the most potent bnAb from this person, they found that it binds to the viral fusion peptide of HIV-1. This region plays a vital role in allowing the virus to gain entry to cells by helping it fuse with the cell membrane. 

The researchers say they are therefore exploring the fusion peptide as a new region of interest for HIV vaccine development.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201162

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Digitally coloured transmission electron micrograph showing a single human immunodeficiency virus (HIV)

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.